{"id":753,"date":"2016-04-27T10:44:50","date_gmt":"2016-04-27T15:44:50","guid":{"rendered":"http:\/\/www.masstortlawyerblog.com\/?p=753"},"modified":"2018-04-23T11:49:04","modified_gmt":"2018-04-23T16:49:04","slug":"prilosec-nexium-associated-increased-risk-chronic-kidney-disease","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/prilosec-nexium-associated-increased-risk-chronic-kidney-disease\/","title":{"rendered":"Prilosec and Nexium Associated with Increased Risk of Chronic Kidney Disease"},"content":{"rendered":"<p>Pharmaceutical companies have made some incredible breakthroughs when it comes to developing drugs that can help people cope with a variety of conditions. In some cases, these drugs can provide a life-changing solution for people who suffer from painful and debilitating conditions. For all their benefits, however, pharmaceuticals can pose serious and life-threatening dangers to patients. Two of the most recent drugs to come under scrutiny\u00a0for posing an unreasonable risk to patients are Prilosec and Nexium. Both drugs are manufactured by AstraZeneca\u00a0and fall within the pharmaceutical\u00a0category of proton pump inhibitors. This type of medication is commonly prescribed to treat gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD). First approved in 1988 under the brand name Losec, Prilosec is a first-generation proton pump inhibitor. Nexium is a second-generation version of the drug that was marketed as an improved version of Prilosec.<\/p>\n<p>According to a recent\u00a0<a href=\"http:\/\/archinte.jamanetwork.com\/article.aspx?articleid=2481153\" target=\"_blank\">study<\/a>\u00a0in\u00a0the Journal of the American Medical Association (JAMA), proton pump inhibitors are associated with an increased risk of chronic kidney disease. The risk of developing this condition increases when\u00a0the patient takes the drug over a prolonged period of time. Cases involving kidney-related conditions have already surfaced in patients who\u00a0have taken Nexium and Prilosec. A man in Tennessee, for example, has been diagnosed as having interstitial nephritis, renal failure, and a heart attack after taking Prilosec and Nexium pursuant to a physician&#8217;s prescription.<\/p>\n<p> <a href=\"https:\/\/www.molllawgroup.com\/blog\/prilosec-nexium-associated-increased-risk-chronic-kidney-disease\/#more-753\" class=\"more-link\">Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmaceutical companies have made some incredible breakthroughs when it comes to developing drugs that can help people cope with a variety of conditions. In some cases, these drugs can provide a life-changing solution for people who suffer from painful and debilitating conditions. For all their benefits, however, pharmaceuticals can pose serious and life-threatening dangers to [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-753","post","type-post","status-publish","format-standard","hentry","category-pharmaceuticals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prilosec and Nexium Associated with Increased Risk of Chronic Kidney Disease &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; April 27, 2016<\/title>\n<meta name=\"description\" content=\"Pharmaceutical companies have made some incredible breakthroughs when it comes to developing drugs that can help people cope with a variety of conditions. &#8212; April 27, 2016\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/prilosec-nexium-associated-increased-risk-chronic-kidney-disease\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Prilosec and Nexium Associated with Increased Risk of Chronic Kidney Disease &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; April 27, 2016\" \/>\n<meta name=\"twitter:description\" content=\"Pharmaceutical companies have made some incredible breakthroughs when it comes to developing drugs that can help people cope with a variety of conditions. &#8212; April 27, 2016\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prilosec and Nexium Associated with Increased Risk of Chronic Kidney Disease &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; April 27, 2016","description":"Pharmaceutical companies have made some incredible breakthroughs when it comes to developing drugs that can help people cope with a variety of conditions. &#8212; April 27, 2016","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/prilosec-nexium-associated-increased-risk-chronic-kidney-disease\/","twitter_card":"summary_large_image","twitter_title":"Prilosec and Nexium Associated with Increased Risk of Chronic Kidney Disease &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; April 27, 2016","twitter_description":"Pharmaceutical companies have made some incredible breakthroughs when it comes to developing drugs that can help people cope with a variety of conditions. &#8212; April 27, 2016","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/prilosec-nexium-associated-increased-risk-chronic-kidney-disease\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/prilosec-nexium-associated-increased-risk-chronic-kidney-disease\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"Prilosec and Nexium Associated with Increased Risk of Chronic Kidney Disease","datePublished":"2016-04-27T15:44:50+00:00","dateModified":"2018-04-23T16:49:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/prilosec-nexium-associated-increased-risk-chronic-kidney-disease\/"},"wordCount":499,"articleSection":["Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/prilosec-nexium-associated-increased-risk-chronic-kidney-disease\/","url":"https:\/\/www.molllawgroup.com\/blog\/prilosec-nexium-associated-increased-risk-chronic-kidney-disease\/","name":"Prilosec and Nexium Associated with Increased Risk of Chronic Kidney Disease &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; April 27, 2016","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"datePublished":"2016-04-27T15:44:50+00:00","dateModified":"2018-04-23T16:49:04+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"Pharmaceutical companies have made some incredible breakthroughs when it comes to developing drugs that can help people cope with a variety of conditions. &#8212; April 27, 2016","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/prilosec-nexium-associated-increased-risk-chronic-kidney-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/prilosec-nexium-associated-increased-risk-chronic-kidney-disease\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/prilosec-nexium-associated-increased-risk-chronic-kidney-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Prilosec and Nexium Associated with Increased Risk of Chronic Kidney Disease"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=753"}],"version-history":[{"count":2,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/753\/revisions"}],"predecessor-version":[{"id":2249,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/753\/revisions\/2249"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}